2023-2024 Vaccine Recomendations

Generic Lab Tubes and Plates

2023-2024 WHO Northern Hemisphere recommendations

24 February 2023

It is recommended that quadrivalent vaccines for use in the 2023-2024 influenza season (Northern Hemisphere winter) contain the following:

Egg based vaccines:

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/9/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • It is recommended that trivalent vaccines for use in the 2023-2024 influenza season (Northern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus
  • an A/Darwin/9/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

    • Full WHO Recommendation

    Top of Page

    AIVC recommendation for the composition of influenza vaccine for Australia in 2023

    6 October 2022

    The AIVC met on 6 October 2022 and recommended that the following viruses be used for influenza vaccines in the 2023 Southern Hemisphere influenza season:

    Egg based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus
  • an A/Darwin/9/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • See the TGA website for further information

    Top of Page

    2023 WHO Southern Hemisphere recommendations

    23 September 2022

    It is recommended that quadrivalent vaccines for use in the 2023 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus
  • an A/Darwin/9/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • It is recommended that trivalent vaccines for use in the 2023 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus
  • an A/Darwin/9/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021(B/Victoria lineage)-like virus

    • Cell or recombinant based vaccines:

  • an A/Sydney/5/2021 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

    • Full WHO Recommendation

    Top of Page

    To view Recommendations from previous years, please click below: